NO173298C - Anvendelse av karbohydratforbindelse med virusbindende egenskaper for in vitro diagnose av virusinfeksjoner eller for fremstilling eller isolering av viruspartikler eller virusoverflatekomponenter - Google Patents
Anvendelse av karbohydratforbindelse med virusbindende egenskaper for in vitro diagnose av virusinfeksjoner eller for fremstilling eller isolering av viruspartikler eller virusoverflatekomponenterInfo
- Publication number
- NO173298C NO173298C NO863646A NO863646A NO173298C NO 173298 C NO173298 C NO 173298C NO 863646 A NO863646 A NO 863646A NO 863646 A NO863646 A NO 863646A NO 173298 C NO173298 C NO 173298C
- Authority
- NO
- Norway
- Prior art keywords
- virus
- isolation
- preparation
- viral infections
- binding properties
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18851—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK17885A DK17885D0 (da) | 1985-01-14 | 1985-01-14 | Antiviralt middel |
PCT/DK1986/000007 WO1986003971A1 (en) | 1985-01-14 | 1986-01-13 | Antiviral agents |
Publications (4)
Publication Number | Publication Date |
---|---|
NO863646D0 NO863646D0 (no) | 1986-09-12 |
NO863646L NO863646L (no) | 1986-11-14 |
NO173298B NO173298B (no) | 1993-08-16 |
NO173298C true NO173298C (no) | 1993-11-24 |
Family
ID=8090653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO863646A NO173298C (no) | 1985-01-14 | 1986-09-12 | Anvendelse av karbohydratforbindelse med virusbindende egenskaper for in vitro diagnose av virusinfeksjoner eller for fremstilling eller isolering av viruspartikler eller virusoverflatekomponenter |
Country Status (11)
Country | Link |
---|---|
US (2) | US4859769A (de) |
EP (1) | EP0207984B1 (de) |
JP (1) | JPS62502260A (de) |
CN (1) | CN86100608A (de) |
AU (1) | AU580136B2 (de) |
DK (1) | DK17885D0 (de) |
FI (1) | FI93227C (de) |
IE (1) | IE59036B1 (de) |
IL (1) | IL77603A (de) |
NO (1) | NO173298C (de) |
WO (1) | WO1986003971A1 (de) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5534553A (en) * | 1987-06-12 | 1996-07-09 | Hoerrmann; Wilhelm | Drug containing fatty amino alcohols or derivatives thereof |
DE3819870A1 (de) * | 1987-06-12 | 1988-12-29 | Hoerrmann Wilhelm | Arzneimittel auf der basis von fett-amino-alkoholen |
US5344870A (en) * | 1987-12-02 | 1994-09-06 | Alberta Research Council | Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
US5079353A (en) * | 1987-12-02 | 1992-01-07 | Chembiomed, Ltd. | Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
WO1989008499A1 (en) * | 1988-03-17 | 1989-09-21 | Nippon Fine Chemical Co., Ltd. | Liposome |
IT1235011B (it) * | 1988-07-26 | 1992-06-16 | Fidia Farmaceutici | Sintesi di derivati di glicosfingolipidi ed in particolare di gangliosidi utilizzabili per la preparazione di immunoadsorbenti ed adsorbenti per affinita' impiegabili per la purificazione di anticorpi e di tossine specifiche, e per uso diagnostico |
US5149782A (en) * | 1988-08-19 | 1992-09-22 | Tanox Biosystems, Inc. | Molecular conjugates containing cell membrane-blending agents |
DE3840044A1 (de) * | 1988-11-27 | 1990-06-07 | Behringwerke Ag | Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung |
US6407072B1 (en) * | 1988-12-02 | 2002-06-18 | Fidia S.P.A. | Lysoganglioside derivatives |
IT1235161B (it) * | 1988-12-02 | 1992-06-22 | Fidia Farmaceutici | Derivati di lisogangliosidi |
US5192551A (en) * | 1989-05-02 | 1993-03-09 | Johns Hopkins University | Neutral glycolipid as an adsorbent for enteric viral pathogens |
WO1991008748A1 (en) * | 1989-12-13 | 1991-06-27 | Glycomed Incorporated | Synthesis of rotavirus receptor saccharides |
WO1991008747A1 (en) * | 1989-12-13 | 1991-06-27 | Glycomed Incorporated | Synthetic receptor molecules recognizable by a rotavirus |
US5466681A (en) * | 1990-02-23 | 1995-11-14 | Microcarb, Inc. | Receptor conjugates for targeting penicillin antibiotics to bacteria |
US6387884B1 (en) | 1990-06-18 | 2002-05-14 | Stanford University | Leukocyte homing modulation |
US6391857B1 (en) | 1990-06-18 | 2002-05-21 | Stanford University | Methods and compositions for endothelial binding |
JP2911554B2 (ja) * | 1990-06-25 | 1999-06-23 | 台糖株式会社 | 抗ウィルス剤 |
CA2065265A1 (en) * | 1990-06-27 | 1991-12-28 | Tadao Shoji | Alkylated oligosaccharides and acetyl derivatives of the same |
JPH06501383A (ja) * | 1990-08-02 | 1994-02-17 | マイクロカーブ インク | 病原体又は日和見感染微生物に対する接着受容体 |
US5843463A (en) * | 1990-12-21 | 1998-12-01 | Antexbiologics, Inc. | Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae |
ATE124262T1 (de) * | 1990-12-21 | 1995-07-15 | Microcarb Inc | Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung. |
US6121233A (en) | 1991-04-19 | 2000-09-19 | John L. Magnani | Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules |
US5936076A (en) * | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
JPH05279381A (ja) * | 1991-09-13 | 1993-10-26 | Dainippon Ink & Chem Inc | 硫酸化オリゴ糖芳香族配糖体 |
GB9219562D0 (en) | 1992-03-11 | 1992-10-28 | Prendergast Kennet F | Anti-viral peptides |
TW261533B (de) * | 1992-07-16 | 1995-11-01 | Kirin Brewery | |
US5849716A (en) * | 1992-10-22 | 1998-12-15 | Kirin Beer Kabushiki Kaisha | Sphingoglycolipids, their preparation, and therapeutic methods of use |
EP0680337A4 (de) * | 1993-01-12 | 1997-07-30 | Anthony George Gristina | Methoden und zusammensetzungen zur direkter konzentrierter verabreichung passiver immunität. |
WO1994024142A1 (en) * | 1993-04-15 | 1994-10-27 | Kirin Beer Kabushiki Kaisha | Novel sphingoglycolipid and use thereof |
CA2171614C (en) * | 1994-07-15 | 2008-04-15 | Mamoru Koketsu | Pharmaceutical composition containing sialic acid derivatives |
US5606512A (en) * | 1994-07-27 | 1997-02-25 | The Dow Chemical Company | Determining the biodegradability of iminodiacetic acid derivatives |
DE69515671T3 (de) * | 1994-07-27 | 2004-06-17 | The Dow Chemical Co., Midland | Bestimmung der biodegradabilität von asparaginsäurederivaten, abbaubare chelatbildner, verwendungen und zusammensetzungen davon |
US5730157A (en) * | 1995-12-07 | 1998-03-24 | Clarion Pharmaceuticals Inc. | Method for treating viral infection |
US5973128A (en) * | 1996-11-22 | 1999-10-26 | The Hospital For Sick Children Research And Development Lp | Glycolipid mimics and methods of use thereof |
US6083921A (en) * | 1998-01-12 | 2000-07-04 | Xu; Kai Jian | Pharmaceutical compositions and method of using same |
CA2359839A1 (en) * | 1999-02-23 | 2000-08-31 | Takara Shuzo Co., Ltd. | Sulfated fucogalactan |
SE9904581D0 (sv) * | 1999-12-15 | 1999-12-15 | A & Science Invest Ab | A novel helicobacter pylori-binding substance and use thereof |
US7135173B2 (en) * | 2000-07-13 | 2006-11-14 | Idaho Research Foundation, Inc. | Antiviral activity of Shiga toxin |
US6541013B1 (en) | 2000-07-13 | 2003-04-01 | Idaho Research Foundation, Inc. | Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide |
DE60232077D1 (de) * | 2001-06-29 | 2009-06-04 | Glykos Finland Oy | Verwendung mindestens einer glycoinhibitor-substanz gegen infektionskrankheiten |
FI20011403A (fi) * | 2001-06-29 | 2002-12-30 | Carbion Oy | Menetelmä ja koostumukset vatsan sairauksien hoitoon |
US7865047B2 (en) * | 2001-12-28 | 2011-01-04 | Prysmian Cavi E Sistemi Energia S.R.L. | Water-resistant telecommunication cable |
AU2003249641B2 (en) | 2002-05-16 | 2009-08-20 | Glycomimetics, Inc. | Compounds and methods for inhibiting selectin-mediated function |
US20040096396A1 (en) * | 2002-07-03 | 2004-05-20 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis |
CN1705488A (zh) * | 2002-10-22 | 2005-12-07 | 独立行政法人科学技术振兴机构 | 登革热病毒感染抑制剂 |
PL377161A1 (pl) * | 2002-11-21 | 2006-01-23 | Pevion Biotech Ltd. | Wysoce efektywne pęcherzyki fuzogenne, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierające te pęcherzyki |
US20040219158A1 (en) * | 2003-05-02 | 2004-11-04 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria |
CA2546784A1 (en) * | 2003-11-19 | 2005-06-16 | Glycomimetics, Inc. | Glycomimetic antagonists for both e- and p-selectins |
US7361644B2 (en) * | 2003-11-19 | 2008-04-22 | Glycomimetics, Inc. | Specific antagonist for both E- and P-selectins |
US8137397B2 (en) * | 2004-02-26 | 2012-03-20 | Boston Scientific Scimed, Inc. | Medical devices |
US8201377B2 (en) * | 2004-11-05 | 2012-06-19 | Faus Group, Inc. | Flooring system having multiple alignment points |
US20090036386A1 (en) * | 2005-05-25 | 2009-02-05 | Glycomimetics, Inc | Heterobifunctional compounds for selectin inhibition |
ATE528311T1 (de) * | 2005-08-09 | 2011-10-15 | Glycomimetics Inc | Glycomimetische inhibitoren des pa-il-lectins, pa-iil-lectins oder beider lectine aus pseudomonas |
PT2264043T (pt) * | 2005-09-02 | 2018-01-19 | Glycomimetics Inc | Inibidores de pan-selectina heterobifuncionais |
WO2007143052A1 (en) * | 2006-06-01 | 2007-12-13 | Glycomimetics, Inc. | Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas |
WO2008060378A2 (en) * | 2006-10-12 | 2008-05-22 | Glycomimetics, Inc. | Glycomimetic replacements for hexoses and n-acetyl hexosamines |
JP5511390B2 (ja) * | 2007-02-09 | 2014-06-04 | グリコミメティクス, インコーポレイテッド | ヘキソースおよびn−アセチルヘキソサミンの置換体を有する糖模倣体の使用方法 |
US8039442B2 (en) * | 2007-07-18 | 2011-10-18 | Glycomimetics, Inc. | Compounds and methods for treatment of sickle cell disease or complications associated therewith |
WO2009126556A1 (en) | 2008-04-08 | 2009-10-15 | Glycomimetics, Inc. | Pan-selectin inhibitor with enhanced pharmacokinetic activity |
CA2727788A1 (en) * | 2008-06-13 | 2009-12-17 | Glycomimetics, Inc. | Treatment of cancers of the blood using selected glycomimetic compounds |
CA2760292A1 (en) * | 2009-05-01 | 2010-11-04 | Glycomimetics, Inc. | Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors |
WO2012037034A1 (en) | 2010-09-14 | 2012-03-22 | Glycomimetics, Inc. | E-selectin antagonists |
PT2794626T (pt) | 2011-12-22 | 2018-01-12 | Glycomimetics Inc | Compostos de antagonistas de e-selectina |
SI2928476T1 (en) | 2012-12-07 | 2018-06-29 | Glycomimetics, Inc. | COMPONENTS, INSTALLATIONS AND PROCEDURES OF THE APPLICATION OF E-SELECTINE OF ANTAGONISTS FOR THE MOBILIZATION OF HEMATOPOETIC CELLS |
HUE045542T2 (hu) | 2014-12-03 | 2019-12-30 | Glycomimetics Inc | E-szelektinek és CXCR4 kemokin receptorok heterobifunkcionális inhibitorai |
CA3009836A1 (en) | 2016-01-22 | 2017-07-27 | Glycomimetics, Inc. | Glycomimetic inhibitors of pa-il and pa-iil lectins |
WO2017151708A1 (en) | 2016-03-02 | 2017-09-08 | Glycomimetics, Inc. | Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin |
EP3497131B1 (de) | 2016-08-08 | 2022-03-09 | GlycoMimetics, Inc. | Kombination von t-zell-checkpoint-inhibitoren mit e-selectin- oder cxcr4-inhibitoren oder mit heterobifunktionellen e-selectin- wie auch cxcr4-inhibitoren |
KR102653723B1 (ko) | 2016-10-07 | 2024-04-01 | 글리코미메틱스, 인크. | 매우 강력한 다량체성 e-셀렉틴 길항물질 |
US11197877B2 (en) | 2017-03-15 | 2021-12-14 | Glycomimetics. Inc. | Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists |
EP3717013A1 (de) | 2017-11-30 | 2020-10-07 | GlycoMimetics, Inc. | Verfahren zur mobilisierung von knochenmarkinfiltrierenden lymphozyten und deren verwendung |
WO2019133878A1 (en) | 2017-12-29 | 2019-07-04 | Glycomimetics, Inc. | Heterobifunctional inhibitors of e-selectin and galectin-3 |
JP7455064B2 (ja) | 2018-03-05 | 2024-03-25 | グリコミメティクス, インコーポレイテッド | 急性骨髄性白血病および関連状態を処置する方法 |
WO2020139962A1 (en) | 2018-12-27 | 2020-07-02 | Glycomimetics, Inc. | Heterobifunctional inhibitors of e-selectin and galectin-3 |
CN114920788B (zh) * | 2022-05-30 | 2024-07-30 | 天津科技大学 | 人乳三糖半乳糖基乳糖的制备 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3622666A (en) * | 1968-03-04 | 1971-11-23 | Stanley Drug Products Inc | Methods for treating bacterial infections with phrenosin |
DE1910715A1 (de) * | 1968-03-04 | 1969-10-09 | Stanley Drug Products Inc | Antimikrobielle Faktoren und deren Verwendung |
DE2322562C2 (de) * | 1972-11-06 | 1984-03-29 | Pharmacia AB, Uppsala | Verfahren zur Bestimmung von Antigenen in einer Probe |
US4056322A (en) * | 1973-12-14 | 1977-11-01 | Strategic Medical Research Corporation | Preparation of ethers of monosaccharides |
US4397844A (en) * | 1978-02-24 | 1983-08-09 | Ciba-Geigy Corporation | Antigen derivatives and processes for their preparation |
FR2478104B1 (fr) * | 1980-03-17 | 1986-08-08 | Merieux Inst | Nouveaux derives de gangliosides, leur preparation et leur application |
US4397959A (en) * | 1980-11-05 | 1983-08-09 | Research Corporation | Forced precipitation method for preparing antigen/antibody particles |
US4476119A (en) * | 1981-08-04 | 1984-10-09 | Fidia S.P.A. | Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions |
AU561067B2 (en) * | 1982-03-22 | 1987-04-30 | Biocarb Ab | Anti-bacterial composition containing an oligosaccharide |
US4678747A (en) * | 1983-02-18 | 1987-07-07 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies for detection of an H (O) blood group antigen |
SE8304007D0 (sv) * | 1983-07-15 | 1983-07-15 | Karlsson Karl Anders | Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling |
IT1168205B (it) * | 1983-07-21 | 1987-05-20 | Wellcome Italia | Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione |
EP0146810A3 (de) * | 1983-12-05 | 1987-05-13 | Solco Basel AG | Verfahren zur Herstellung von Sphingosinderivaten |
US4695553A (en) * | 1985-11-01 | 1987-09-22 | Becton Dickinson And Co., Inc. | Method for increasing agglutination of groups of cells to produce improved cell layer interface in centrifuged blood sample using antibodies |
-
1985
- 1985-01-14 DK DK17885A patent/DK17885D0/da not_active Application Discontinuation
-
1986
- 1986-01-10 IE IE7586A patent/IE59036B1/en not_active IP Right Cessation
- 1986-01-13 EP EP19860900753 patent/EP0207984B1/de not_active Expired - Lifetime
- 1986-01-13 AU AU53513/86A patent/AU580136B2/en not_active Ceased
- 1986-01-13 US US06/916,542 patent/US4859769A/en not_active Expired - Fee Related
- 1986-01-13 WO PCT/DK1986/000007 patent/WO1986003971A1/en active IP Right Grant
- 1986-01-13 JP JP61500832A patent/JPS62502260A/ja active Pending
- 1986-01-14 IL IL7760386A patent/IL77603A/en not_active IP Right Cessation
- 1986-01-14 CN CN198686100608A patent/CN86100608A/zh active Pending
- 1986-09-12 FI FI863702A patent/FI93227C/fi not_active IP Right Cessation
- 1986-09-12 NO NO863646A patent/NO173298C/no unknown
-
1989
- 1989-06-19 US US07/368,188 patent/US4980462A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI93227C (fi) | 1995-03-10 |
EP0207984B1 (de) | 1991-07-03 |
FI863702A0 (fi) | 1986-09-12 |
AU5351386A (en) | 1986-07-29 |
IL77603A (en) | 1994-12-29 |
AU580136B2 (en) | 1989-01-05 |
EP0207984A1 (de) | 1987-01-14 |
NO863646D0 (no) | 1986-09-12 |
JPS62502260A (ja) | 1987-09-03 |
US4980462A (en) | 1990-12-25 |
FI863702A (fi) | 1986-09-12 |
WO1986003971A1 (en) | 1986-07-17 |
FI93227B (fi) | 1994-11-30 |
US4859769A (en) | 1989-08-22 |
IE59036B1 (en) | 1993-12-15 |
NO173298B (no) | 1993-08-16 |
CN86100608A (zh) | 1987-02-18 |
NO863646L (no) | 1986-11-14 |
IE860075L (en) | 1986-07-14 |
DK17885D0 (da) | 1985-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO173298C (no) | Anvendelse av karbohydratforbindelse med virusbindende egenskaper for in vitro diagnose av virusinfeksjoner eller for fremstilling eller isolering av viruspartikler eller virusoverflatekomponenter | |
EP0192001A3 (en) | Papilloma virus probes and in vitro methods for the diagnosis of papilloma virus infections | |
IT1196032B (it) | Procedimento per la preparazione di vaccini polivalenti adsrobiti liofilizzati | |
LV10654B (en) | Method for preparation of diagnostic composition and the use thereof | |
MX5712A (es) | Procedimiento para la preparacion de compuestos esteroides y compuestos obtenidos | |
IT1131109B (it) | Procedimento per la preparazione di concentrati di complesso portrombinico ad alta purezza e concentrati ottenuti | |
DK130983D0 (da) | Fremgangsmade til fremstilling af terapeutiske eller diagnostiske praeparater | |
DK131083D0 (da) | Fremgangsmade til fremstilling af terapeutiske eller diagnostiske praeparater | |
NO880935D0 (no) | Fremgangmsaate for paavisning av hiv eller annet virus med lignende klinisk virkning. | |
ZA813479B (en) | Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccines | |
PT87004A (pt) | Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine | |
GB2199038B (en) | Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies | |
FR2585326B3 (fr) | Configuration d'arriere de fuselage d'avion | |
IT1191849B (it) | Procedimento per la preparazione di chetoni | |
IT1223485B (it) | Procedimento per la preparazione di componenti ceramici | |
PT83787B (en) | Improved process for the laboratory diagnosis of infections caused by htlv 222 virus in particular | |
GB2199326B (en) | Polypeptidic composition useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antimerozoite antibodies | |
IT8368106A0 (it) | Dispositivo di filtraggio per l aria di aspirazione di motori di aeromobili in particolare elicotteri | |
ZA874778B (en) | Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections | |
IT8048117A0 (it) | Composizione per il trattamento di infezioni virali e procedimento di preparazione | |
IT7948752A0 (it) | Vaccino per il virus della parainfluenza e suo procedimento di preparazione | |
IT1157531B (it) | Procedimento per la preparazione di bevande calde mediante l'uso preferibilmente di sostanze solubili o liofilizzate | |
DK397583D0 (da) | Fremgangsmade til fremstilling af 1-substituerede cycliske lactam-2-carboxylsyrer eller derivater deraf | |
ES555070A0 (es) | Procedimiento para la preparacion y construccion de suelos elasticos | |
IE860983L (en) | Antigens related to envelope glycoprotein of the virus of¹aids |